ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 17, 2008 | $45,000 | Replaced |
| 2nd Quarter - Amendment | Aug 6, 2009 | $344,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Increased federal funding for comparative effectiveness research, legislation relating to health information technology and electronic prescribing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| RYAN DAY | — |
| LAUREN LEA FULLER New | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Medicare/Medicaid MMM
Proposed changes to Medicare Part D prescription drug benefit. Adjustments to Medicaid prescription drug reimbursement rates (calculation of average manufacturer's price).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| RYAN DAY | — |
| LAUREN LEA FULLER New | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Labor Issues/Antitrust/Workplace LBR
Legislation granting independent and community pharmacists collective bargaining rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| RYAN DAY | — |
| LAUREN LEA FULLER New | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Pharmacy PHA
Establishing a regulatory pathway for Food and Drug Administration approval of follow-on biologic products, electronic prescribing of controlled substances, regulation of online pharmacies, importation of prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| RYAN DAY | — |
| LAUREN LEA FULLER New | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.